News

Istari Oncology Hires Marc Banjak as General Counsel and Secretary as the Company Prepares for a Critical Period of Development and Expansion

April 29, 2021

Istari Oncology Hires Marc Banjak as General Counsel and Secretary as the Company Prepares for…

April 21, 2021

Istari Oncology Announces Publication of Phase 1 Data Showing PVSRIPO Immunotherapy Leads to Objective Responses…

April 19, 2021

Istari Oncology Announces FDA Clearance of IND to Initiate LUMINOS-103: A Basket Trial Evaluating the…

April 6, 2021

Istari Oncology Abstracts to be Presented at the American Association for Cancer Research (AACR) 2021…

March 31, 2021

Istari Oncology Announces First Patient Dosed in the LUMINOS-102 Phase 2 Clinical Trial of PVSRIPO…

March 25, 2021

Istari Oncology Announces Publication of Data Showing the Investigational Immunotherapy PVSRIPO Leads to Robust, Functional…

March 15, 2021

From the office of UConn Health: High-Profile Brain Tumor Trial Chooses UConn Health An immunotherapy…

January 10, 2021

Istari Oncology Announces FDA Grants Orphan Drug Designation for PVSRIPO for the Treatment of Advanced…

November 30, 2020

Istari Oncology Announces First Patient Dosed in the LUMINOS-101 Phase 2 Clinical Trial of PVSRIPO…

November 17, 2020

From the office of University Hospitals Seidman Cancer Center: UH Seidman Cancer Center Opens New…